<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Res Med Sci</journal-id><journal-id journal-id-type="publisher-id">JRMS</journal-id><journal-title-group><journal-title>Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1735-1995</issn><issn pub-type="epub">1735-7136</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23798921</article-id><article-id pub-id-type="pmc">3685777</article-id><article-id pub-id-type="publisher-id">JRMS-17-626</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of low calorie diet with rice bran oil on cardiovascular risk factors in hyperlipidemic patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zavoshy</surname><given-names>Rosa</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Noroozi</surname><given-names>Mostafa</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Jahanihashemi</surname><given-names>Hassan</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">Department and Laboratory of Human Nutrition, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran</aff><aff id="aff2"><label>1</label>Department of Biostatistics, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Mostafa Noroozi, Department and Laboratory of Human Nutrition, Faculty of Medicine, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin, Post Code - 34197-59811, Iran. E-mail: <email xlink:href="mnoroozi@ymail.com">mnoroozi@ymail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2012</year></pub-date><volume>17</volume><issue>7</issue><fpage>626</fpage><lpage>631</lpage><history><date date-type="received"><day>24</day><month>1</month><year>2012</year></date><date date-type="rev-recd"><day>13</day><month>4</month><year>2012</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2012</year></date></history><permissions><copyright-statement>Copyright: © Journal of Research in Medical Sciences</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3366" xml_f="3377" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="3388" xml_f="3647" txt_i="23" txt_f="282">Cardiovascular disease remains the leading cause of death and disability in industrialized and developing countries. The aim of this research was to determine the effect of rice bran oil, with a low-calorie diet, on lipid profiles, in hyperlipidemic patients.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3678" xml_f="3700" txt_i="284" txt_f="306">Materials and Methods:</offsets></title><p><offsets xml_i="3711" xml_f="4438" txt_i="307" txt_f="1034">This study was a parallel groups’ randomized clinical trial with a pre- and post-test design. Fifty hyperlipidemic patients of both sexes and age range of 25 – 65 years had participated. The patients received a low-calorie diet based on 1400 kcal energy, 17% protein, 26% fat, and 57% carbohydrate per day for four weeks. The treatment group received a low-calorie diet including rice bran oil (30 g / day). Blood samples were obtained after an overnight (12 hours) fasting period before the study and on the last day of the intervention period. Anthropometric indices and levels of serum triacylglycerol, total cholesterol, low-density lipoprotein, and high-density lipoprotein were measured before and after the intervention.</offsets></p></sec><sec id="st3"><title><offsets xml_i="4469" xml_f="4477" txt_i="1036" txt_f="1044">Results:</offsets></title><p><offsets xml_i="4488" xml_f="4587" txt_i="1045" txt_f="1144">In both groups, weight, body mass index, waist, and hip circumferences were significantly reduced (</offsets><italic><offsets xml_i="4595" xml_f="4596" txt_i="1144" txt_f="1145">P</offsets></italic><offsets xml_i="4605" xml_f="4930" txt_i="1145" txt_f="1467"> &lt; 0.05) after four weeks. In comparison with the control group, the results of treatment with rice bran oil, with a low-calorie diet, showed that at the end of the fourth week, total cholesterol, low-density lipoprotein, and atherogenic ratio of total cholesterol / high-density lipoprotein were significantly decreased (</offsets><italic><offsets xml_i="4938" xml_f="4939" txt_i="1467" txt_f="1468">P</offsets></italic><offsets xml_i="4948" xml_f="4960" txt_i="1468" txt_f="1477"> &lt; 0.05).</offsets></p></sec><sec id="st4"><title><offsets xml_i="4991" xml_f="5003" txt_i="1479" txt_f="1491">Conclusions:</offsets></title><p><offsets xml_i="5014" xml_f="5161" txt_i="1492" txt_f="1639">The results confirm that rice bran oil, when consumed as part of a healthy diet, is effective in improving risk factors for cardiovascular disease.</offsets></p></sec></abstract><kwd-group><kwd>Cardiovascular disease</kwd><kwd>diet</kwd><kwd>low density lipoprotein</kwd><kwd>rice bran oil</kwd><kwd>total cholesterol
</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title><offsets xml_i="5393" xml_f="5405" txt_i="1648" txt_f="1660">INTRODUCTION</offsets></title><p><offsets xml_i="5416" xml_f="5773" txt_i="1661" txt_f="2018">Cardiovascular diseases (CVD) have emerged as a major health burden worldwide in recent times. Observational studies on distinct populations support the existence of a linear relationship between plasma lipid levels and cardiovascular disease-induced death rate. This is found to be true, even if the elevated plasma cholesterol is at the borderline level.[</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="5806" xml_f="5807" txt_i="2018" txt_f="2019">1</offsets></xref><offsets xml_i="5814" xml_f="5940" txt_i="2019" txt_f="2145">] The composition of the diet plays an important role in the management of lipid and lipoprotein concentrations in the blood.[</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="5973" xml_f="5974" txt_i="2145" txt_f="2146">2</offsets></xref><offsets xml_i="5981" xml_f="6039" txt_i="2146" txt_f="2204">] Rice bran oil (RBO) is now emerging as an everyday oil.[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="6072" xml_f="6073" txt_i="2204" txt_f="2205">3</offsets></xref><offsets xml_i="6080" xml_f="6409" txt_i="2205" txt_f="2534">] Rice bran is a by-product of the rice milling industry, separated from the white portion of the rice in the polishing process. Human consumption has been traditionally limited because of the bran's instability and the rapid onset of rancidity produced by a high lipase activity in the bran causing deterioration of the lipids.[</offsets><xref ref-type="bibr" rid="ref4"><offsets xml_i="6442" xml_f="6443" txt_i="2534" txt_f="2535">4</offsets></xref><offsets xml_i="6450" xml_f="6520" txt_i="2535" txt_f="2605">] However, improved oil extraction methods have reduced this problem.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="6553" xml_f="6554" txt_i="2605" txt_f="2606">5</offsets></xref><offsets xml_i="6561" xml_f="6626" txt_i="2606" txt_f="2671">] Also, high levels of unsaponifiable material are found in RBO.[</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="6659" xml_f="6660" txt_i="2671" txt_f="2672">6</offsets></xref><offsets xml_i="6667" xml_f="6974" txt_i="2672" txt_f="2979">] This is composed of plant sterols, triterpene alcohols, ferulic acid esters (γoryzanol), and vitamin E isomers (tocopherols and tocotrienols). In addition, RBO contains up to 20% saturated fatty acids (SFA) and equal amounts of mono unsaturated fatty acids (MUFA) and poly unsaturated fatty acids (PUFA).[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="7007" xml_f="7008" txt_i="2979" txt_f="2980">3</offsets></xref><offsets xml_i="7015" xml_f="7115" txt_i="2980" txt_f="3080">] RBO has a mild flavor and high smoking point, making it suitable for use in many cooking methods.[</offsets><xref ref-type="bibr" rid="ref7"><offsets xml_i="7148" xml_f="7149" txt_i="3080" txt_f="3081">7</offsets></xref><offsets xml_i="7156" xml_f="7309" txt_i="3081" txt_f="3234">] Consumption of a diet with RBO induces a decrease in the plasma level of total cholesterol (TC) and low-density lipoprotein (LDL) in healthy subjects,[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="7342" xml_f="7343" txt_i="3234" txt_f="3235">8</offsets></xref><offsets xml_i="7350" xml_f="7351" txt_i="3235" txt_f="3236">–</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="7385" xml_f="7387" txt_i="3236" txt_f="3238">10</offsets></xref><offsets xml_i="7394" xml_f="7424" txt_i="3238" txt_f="3268">] in hyperlipidemic patients,[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="7458" xml_f="7460" txt_i="3268" txt_f="3270">11</offsets></xref><xref ref-type="bibr" rid="ref12"><offsets xml_i="7501" xml_f="7503" txt_i="3270" txt_f="3272">12</offsets></xref><offsets xml_i="7510" xml_f="7544" txt_i="3272" txt_f="3306">] in nephrotic syndrome children,[</offsets><xref ref-type="bibr" rid="ref13"><offsets xml_i="7578" xml_f="7580" txt_i="3306" txt_f="3308">13</offsets></xref><offsets xml_i="7587" xml_f="7611" txt_i="3308" txt_f="3332">] and also in hamsters,[</offsets><xref ref-type="bibr" rid="ref14"><offsets xml_i="7645" xml_f="7647" txt_i="3332" txt_f="3334">14</offsets></xref><offsets xml_i="7654" xml_f="7730" txt_i="3334" txt_f="3410">] but there has been no significant effect on plasma triacylglycerol (TAG).[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="7763" xml_f="7764" txt_i="3410" txt_f="3411">9</offsets></xref><offsets xml_i="7771" xml_f="7962" txt_i="3411" txt_f="3602">] However, a three-month diet supplemented with RBO in hyperlipidemic patients showed a significant reduction in plasma TAG, but high-density lipoprotein (HDL) and LDL levels were unchanged.[</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="7996" xml_f="7998" txt_i="3602" txt_f="3604">15</offsets></xref><offsets xml_i="8005" xml_f="8035" txt_i="3604" txt_f="3634">] Moreover, in a recent study[</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="8069" xml_f="8071" txt_i="3634" txt_f="3636">16</offsets></xref><offsets xml_i="8078" xml_f="8264" txt_i="3636" txt_f="3822">] on mildly hypercholesterolemic individuals, a dietary intervention of RBO spread over twelve weeks was reported to have had no significant change on TAG and HDL, although Lichtenstein </offsets><italic><offsets xml_i="8272" xml_f="8277" txt_i="3822" txt_f="3827">et al</offsets></italic><offsets xml_i="8286" xml_f="8288" txt_i="3827" txt_f="3829">.[</offsets><xref ref-type="bibr" rid="ref17"><offsets xml_i="8322" xml_f="8324" txt_i="3829" txt_f="3831">17</offsets></xref><offsets xml_i="8331" xml_f="8573" txt_i="3831" txt_f="4073">] observed that the dietary supplement of RBO in middle-aged and elderly subjects for 32 days resulted in a significant reduction in HDL. In our previous studies, a low-calorie diet with soy protein in hyperlipidemic type 2 diabetic patients[</offsets><xref ref-type="bibr" rid="ref18"><offsets xml_i="8607" xml_f="8609" txt_i="4073" txt_f="4075">18</offsets></xref><offsets xml_i="8616" xml_f="8650" txt_i="4075" txt_f="4109">] and in hyperlipidemic patients,[</offsets><xref ref-type="bibr" rid="ref19"><offsets xml_i="8684" xml_f="8686" txt_i="4109" txt_f="4111">19</offsets></xref><offsets xml_i="8693" xml_f="8738" txt_i="4111" txt_f="4156">] also dietary intervention with canola oil,[</offsets><xref ref-type="bibr" rid="ref20"><offsets xml_i="8772" xml_f="8774" txt_i="4156" txt_f="4158">20</offsets></xref><offsets xml_i="8781" xml_f="9120" txt_i="4158" txt_f="4497">] as a part of healthy diet, improved the lipid profile. The effect of RBO, with a low-calorie diet, on blood lipids in hyperlipidemic patients has not been studied thoroughly. Hence, the objective of this study was to investigate the effect of RBO, with low-calorie diet, on blood lipids, TAG, TC, LDL, and HDL in hyperlipidemic patients.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="9183" xml_f="9204" txt_i="4499" txt_f="4520">MATERIALS AND METHODS</offsets></title><sec id="sec2-1"><title><offsets xml_i="9236" xml_f="9248" txt_i="4521" txt_f="4533">Participants</offsets></title><p><offsets xml_i="9259" xml_f="9672" txt_i="4534" txt_f="4947">This study was a parallel groups’ randomized clinical trial with a pre- and post-test design. The study was conducted on 50 hyperlipidemic patients who were healthy in other respects and were recruited from the Nutrition and Diet Therapy Clinic, in Qazvin, Iran, in 2011. The inclusion criteria required the age to be 25 – 65 years. The subjects had to hsave at least one of the blood lipid indices, including TC </offsets><sup><offsets xml_i="9677" xml_f="9678" txt_i="4947" txt_f="4948">3</offsets></sup><offsets xml_i="9684" xml_f="9704" txt_i="4948" txt_f="4968"> 200, HDL £ 40, LDL </offsets><sup><offsets xml_i="9709" xml_f="9710" txt_i="4968" txt_f="4969">3</offsets></sup><offsets xml_i="9716" xml_f="9730" txt_i="4969" txt_f="4983"> 130, and TAG </offsets><sup><offsets xml_i="9735" xml_f="9736" txt_i="4983" txt_f="4984">3</offsets></sup><offsets xml_i="9742" xml_f="9971" txt_i="4984" txt_f="5213"> 150 mg / dl. Exclusion criteria included pregnancy and lactation, smoking, steroid therapy, taking lipid-lowering drugs, hormone and a personal history of nephropathy, cardiovascular disease, diabetes, and other chronic disease.</offsets></p></sec><sec id="sec2-2"><title><offsets xml_i="10005" xml_f="10013" txt_i="5215" txt_f="5223">Protocol</offsets></title><p><offsets xml_i="10024" xml_f="10284" txt_i="5224" txt_f="5484">Fifty subjects (42 females and eight males) participated in this study. For sample size determination we consider total cholesterol (TC) as the target parameter with a mean of ≈ 225 mg / dl and standard deviation ≈ 30 mg / dl, according to our previous study.[</offsets><xref ref-type="bibr" rid="ref19"><offsets xml_i="10318" xml_f="10320" txt_i="5484" txt_f="5486">19</offsets></xref><offsets xml_i="10327" xml_f="10423" txt_i="5486" txt_f="5582">] For α=0.0, β=0.2, d = 25 mg / dl (relative error = 11%), we got a sample size for each group, </offsets><italic><offsets xml_i="10431" xml_f="10432" txt_i="5582" txt_f="5583">n</offsets></italic><offsets xml_i="10441" xml_f="12435" txt_i="5583" txt_f="7577"> = 23. We made 25 blocks with two subjects in each. The subjects in each block were similar (match). By two color cards, the subjects in each block were randomly assigned to the case and control groups. All subjects received a low-calorie diet, 1400 Kcal energy per day for four weeks, including 26% fat, 17% proteins, and 57% carbohydrates, from a registered dietitian. The treatment group received the low-calorie diet including (30 g / day) RBO. Rice bran oil was prepared by the Arian Top Noosh Company, Tehran, Iran, for rice bran oil (King rice bran oil, Bangkok, Thailand) dedication. The rice bran oil used had a national quality control certificate number 6650. The low-calorie diet with rice bran oil was well-tolerated and accepted in all cases. Oral and written instructions for recording foods were given to all subjects by the clinical nutritionist. All patients gave informed consent for their participation in the study after reading the protocol of this experiment and receiving information about rice bran oil consumption. Consent was obtained from each patient. They could quit the study freely. All participants provided informed written consent. The protocol was approved by the Research Council and Ethical Committee of the Qazvin University of Medical Sciences. This clinical trail is registered in ClinicalTrail.gov by number, NCD: Seven-day food records and the main daily nutrient intake record, completed during the last week of the study by subjects. All these records were reviewed by the clinical nutritionist for checking the diet compliance. Subjects’ compliance was assessed by analyzing seven days’ diet records. It was analyzed by using a computerized nutrient database (Dorosty Food Processor-DFP, version 2003, Shahid Beheshti University, Tehran, Iran), which was mainly based on the national nutrient composition data. Blood samples were obtained after an overnight (12 hours) fasting period before the study and on the last day of the intervention period.</offsets></p></sec><sec id="sec2-3"><title><offsets xml_i="12469" xml_f="12481" txt_i="7579" txt_f="7591">Measurements</offsets></title><p><offsets xml_i="12492" xml_f="12931" txt_i="7592" txt_f="8031">Anthropometric indices and levels of serum TAG, TC, LDL, and HDL were measured before and after the intervention. Serum TC and TAG concentration were measured by commercially available enzymatic reagents (Pars Azmoon, Tehran, Iran) adopted to the Selectra autoanalyzer (Vital Scientific, Spankeren, Netherlands). HDL-cholesterol was measured after precipitation of the apolipoprotein B containing lipoproteins with phosphotungistic acids.[</offsets><xref ref-type="bibr" rid="ref21"><offsets xml_i="12965" xml_f="12967" txt_i="8031" txt_f="8033">21</offsets></xref><offsets xml_i="12974" xml_f="13412" txt_i="8033" txt_f="8471">] Inter- and intra-assay coefficients of variation were both less than 5% for all these measurements. Body weight was measured when minimally clothed, without shoes, with digital scales. Height was measured in a standing position, with the shoulders in a normal state, without shoes, using a tape meter. Waist circumference was measured to the nearest 0.1 cm at the narrowest level over light clothing, using an unstretched tape measure.[</offsets><xref ref-type="bibr" rid="ref22"><offsets xml_i="13446" xml_f="13448" txt_i="8471" txt_f="8473">22</offsets></xref><offsets xml_i="13455" xml_f="13557" txt_i="8473" txt_f="8575">] During the study, the participants were asked not to change their habitual physical activity levels.</offsets></p></sec><sec id="sec2-4"><title><offsets xml_i="13591" xml_f="13611" txt_i="8577" txt_f="8597">Statistical analysis</offsets></title><p><offsets xml_i="13622" xml_f="13763" txt_i="8598" txt_f="8739">Results are presented as mean ± standard deviation. Data were analyzed with the SPSS package Version 13 (SPSS Inc., Chicago. IL). The paired </offsets><italic><offsets xml_i="13771" xml_f="13772" txt_i="8739" txt_f="8740">t</offsets></italic><offsets xml_i="13781" xml_f="13896" txt_i="8740" txt_f="8855">-test was applied to determine the difference between the before and after measurements and two independent sample </offsets><italic><offsets xml_i="13904" xml_f="13905" txt_i="8855" txt_f="8856">t</offsets></italic><offsets xml_i="13914" xml_f="14063" txt_i="8856" txt_f="9005">- tests were used for analysis of differences between the groups. The Kolmogorov Smirnov test for checking the normality of lipid profiles was used. </offsets><italic><offsets xml_i="14071" xml_f="14072" txt_i="9005" txt_f="9006">P</offsets></italic><offsets xml_i="14081" xml_f="14154" txt_i="9006" txt_f="9076">-Value &lt; 0.05 was accepted as statistically significant for all tests.</offsets></p></sec></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="14213" xml_f="14220" txt_i="9079" txt_f="9086">RESULTS</offsets></title><p><offsets xml_i="14231" xml_f="14484" txt_i="9087" txt_f="9340">The mean age of subjects was 41.86 ± 9.65 years and the average of weight, waist, and hip were 83.87 ± 14.15 kg, 107.16 ± 13.18 cm, and 112.28 ± 16.90 cm, respectively. The mean body mass index (BMI) and waist-to-hip ratio (WHR) were 33.06 ± 4.44 kg / m</offsets><sup><offsets xml_i="14489" xml_f="14490" txt_i="9340" txt_f="9341">2</offsets></sup><offsets xml_i="14496" xml_f="14528" txt_i="9341" txt_f="9373"> and 0.45 ± 0.06, respectively [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="14560" xml_f="14567" txt_i="9373" txt_f="9380">Table 1</offsets></xref><offsets xml_i="14574" xml_f="14785" txt_i="9380" txt_f="9591">]. There were no significant differences in age, weight, height, waist, hip, BMI, WHR, TC, TAG, LDL, HDL, LDL/HDL or atherogenic ratio of TC / HDL between the two groups (treatment and control) at the baseline [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="14817" xml_f="14824" txt_i="9591" txt_f="9598">Table 2</offsets></xref><offsets xml_i="14831" xml_f="14975" txt_i="9598" txt_f="9742">]. The Kolmogorov Smirnov test was used for checking the normality of Cholesterol, TAG, LDL, and HDL in two groups (treatment and control). All </offsets><italic><offsets xml_i="14983" xml_f="14984" txt_i="9742" txt_f="9743">P</offsets></italic><offsets xml_i="14993" xml_f="15130" txt_i="9743" txt_f="9880">-values were between 0.160 and 0.854, which indicated that the normality assumption was accepted. Both groups lost weight significantly (</offsets><italic><offsets xml_i="15138" xml_f="15139" txt_i="9880" txt_f="9881">P</offsets></italic><offsets xml_i="15148" xml_f="15230" txt_i="9881" txt_f="9960"> &lt; 0.05), and BMI and waist and hip circumferences were significantly reduced (</offsets><italic><offsets xml_i="15238" xml_f="15239" txt_i="9960" txt_f="9961">P</offsets></italic><offsets xml_i="15248" xml_f="15291" txt_i="9961" txt_f="10001"> &lt; 0.05) after four weeks of treatment [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="15323" xml_f="15330" txt_i="10001" txt_f="10008">Table 3</offsets></xref><offsets xml_i="15337" xml_f="15771" txt_i="10008" txt_f="10442">]. There were no significant differences at the beginning of dietary intervention (baseline) between the plasma lipid concentrations. A low calorie-diet including RBO intervention resulted in significantly lower levels of TC, LDL, and ratio of TC / HDL than in the baseline (231.92 ± 25.3 mg / dl versus 206.92 ± 25.50 mg / dl, 132.41 ± 14.73 mg / dl versus 122.34 ± 19.78 mg / dl, and 5.30 ± 1.21 versus 4.78 ± 1.04, respectively), (</offsets><italic><offsets xml_i="15779" xml_f="15780" txt_i="10442" txt_f="10443">P</offsets></italic><offsets xml_i="15789" xml_f="15934" txt_i="10443" txt_f="10585"> &lt; 0.05). No significant change occurred in HDL or LDL / HDL. Lipid profiles before and after intervention, in both groups, are summarized in </offsets><xref ref-type="table" rid="T3"><offsets xml_i="15966" xml_f="15973" txt_i="10585" txt_f="10592">Table 3</offsets></xref><offsets xml_i="15980" xml_f="16135" txt_i="10592" txt_f="10747">. Total cholesterol was significantly decreased only in the treatment group, the differences (before minus after) between the two groups were significant [</offsets><italic><offsets xml_i="16143" xml_f="16144" txt_i="10747" txt_f="10748">P</offsets></italic><offsets xml_i="16153" xml_f="16163" txt_i="10748" txt_f="10758"> = 0.030, </offsets><xref ref-type="table" rid="T3"><offsets xml_i="16195" xml_f="16202" txt_i="10758" txt_f="10765">Table 3</offsets></xref><offsets xml_i="16209" xml_f="16211" txt_i="10765" txt_f="10767">].</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="16259" xml_f="16266" txt_i="10768" txt_f="10775">Table 1</offsets></label><caption><p><offsets xml_i="16286" xml_f="16317" txt_i="10775" txt_f="10806">Characteristics of all patients</offsets></p></caption><graphic xlink:href="JRMS-17-626-g001"></graphic></table-wrap><table-wrap id="T2" position="float"><label><offsets xml_i="16437" xml_f="16444" txt_i="10807" txt_f="10814">Table 2</offsets></label><caption><p><offsets xml_i="16464" xml_f="16500" txt_i="10814" txt_f="10850">Baseline characteristics of patients</offsets></p></caption><graphic xlink:href="JRMS-17-626-g002"></graphic></table-wrap><table-wrap id="T3" position="float"><label><offsets xml_i="16620" xml_f="16627" txt_i="10851" txt_f="10858">Table 3</offsets></label><caption><p><offsets xml_i="16647" xml_f="16704" txt_i="10858" txt_f="10915">Characteristics of patients before and after intervention</offsets></p></caption><graphic xlink:href="JRMS-17-626-g003"></graphic></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="16832" xml_f="16842" txt_i="10917" txt_f="10927">DISCUSSION</offsets></title><p><offsets xml_i="16853" xml_f="17057" txt_i="10928" txt_f="11132">Contrary to traditional notions of cardiovascular disease (CVD) as a ‘western’ disease of ‘affluence’, more than three-quarters of global CVD mortality now occurs in the middle- and lower-income nations.[</offsets><xref ref-type="bibr" rid="ref23"><offsets xml_i="17091" xml_f="17093" txt_i="11132" txt_f="11134">23</offsets></xref><offsets xml_i="17100" xml_f="17198" txt_i="11134" txt_f="11232">] Elevations in serum TC and LDL increase the risk of atherosclerosis and coronary heart disease.[</offsets><xref ref-type="bibr" rid="ref14"><offsets xml_i="17232" xml_f="17234" txt_i="11232" txt_f="11234">14</offsets></xref><offsets xml_i="17241" xml_f="17434" txt_i="11234" txt_f="11427">] Dietary modification, for example, the dietary approach to stop hypertension (DASH)-diet is rich in fruits, vegetables, and whole grains and low in saturated fat, total fat, and cholesterol,[</offsets><xref ref-type="bibr" rid="ref24"><offsets xml_i="17468" xml_f="17470" txt_i="11427" txt_f="11429">24</offsets></xref><offsets xml_i="17477" xml_f="17964" txt_i="11429" txt_f="11916">] and is the preferable form of treatment for most types of hyperlipidemia. The present study shows that treatment with a diet containing RBO, for four weeks, results in a significant decrease in the levels of TC, LDL, and atherogenic ratio of TC / HDL by 10.3, 8.6, and 7.1%, respectively. These findings are in agreement with a recent report, which shows that consumption of RBO spread for four weeks significantly reduces blood TC and LDL, in mildly hypercholesterolemic individuals.[</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="17998" xml_f="18000" txt_i="11916" txt_f="11918">16</offsets></xref><offsets xml_i="18007" xml_f="18149" txt_i="11918" txt_f="12060">] In several studies, similar to the result of this study, diet treatment with RBO has resulted significantly in the reduction of TC and LDL.[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="18183" xml_f="18185" txt_i="12060" txt_f="12062">11</offsets></xref><xref ref-type="bibr" rid="ref12"><offsets xml_i="18226" xml_f="18228" txt_i="12062" txt_f="12064">12</offsets></xref><xref ref-type="bibr" rid="ref25"><offsets xml_i="18269" xml_f="18271" txt_i="12064" txt_f="12066">25</offsets></xref><xref ref-type="bibr" rid="ref26"><offsets xml_i="18312" xml_f="18314" txt_i="12066" txt_f="12068">26</offsets></xref><offsets xml_i="18321" xml_f="18704" txt_i="12068" txt_f="12451">] LDL cholesterol has been the focus of much research, as it is conclusively linked to atherosclerosis, coronary heart disease (CHD) development, and acute clinical events, including myocardial infarction (MI) and stroke. Consequently LDL is the primary target for intervention efforts. A decrease of 1 mg / dl in LDL results in about a 1 to 2% decrease in the relative risk for CVD[</offsets><xref ref-type="bibr" rid="ref27"><offsets xml_i="18738" xml_f="18740" txt_i="12451" txt_f="12453">27</offsets></xref><offsets xml_i="18747" xml_f="18818" txt_i="12453" txt_f="12524">] and a 10% reduction in TC would decrease CHD incidence by about 30%.[</offsets><xref ref-type="bibr" rid="ref28"><offsets xml_i="18852" xml_f="18854" txt_i="12524" txt_f="12526">28</offsets></xref><offsets xml_i="18861" xml_f="18920" txt_i="12526" txt_f="12585">] High levels of unsaponifiable material are found in RBO.[</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="18953" xml_f="18954" txt_i="12585" txt_f="12586">6</offsets></xref><offsets xml_i="18961" xml_f="19161" txt_i="12586" txt_f="12786">] This is composed of phytosterols (γ-oryzanol), triterpene alcohols, and vitamin E isomers (tocopherols and tocotrienols). In addition, RBO contains up to 20% SFA and equal amounts of MUFA and PUFA.[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="19194" xml_f="19195" txt_i="12786" txt_f="12787">3</offsets></xref><offsets xml_i="19202" xml_f="19203" txt_i="12787" txt_f="12788">]</offsets></p><p><offsets xml_i="19210" xml_f="19374" txt_i="12789" txt_f="12953">A 10-week feeding study was performed in 14 volunteers, who consumed a diet with RBO, substituted for oil that had a fatty acid composition similar to that of RBO.[</offsets><xref ref-type="bibr" rid="ref25"><offsets xml_i="19408" xml_f="19410" txt_i="12953" txt_f="12955">25</offsets></xref><offsets xml_i="19417" xml_f="19747" txt_i="12955" txt_f="13285">] Their results confirmed the previous findings of the total and LDL-cholesterol-lowering effects of RBO in humans. When matching the fatty acids of the RBO with control oil, they showed that the effect of RBO on serum cholesterol concentrations was due to the unsaponifiables present in it and not due to its fatty acid profile.[</offsets><xref ref-type="bibr" rid="ref25"><offsets xml_i="19781" xml_f="19783" txt_i="13285" txt_f="13287">25</offsets></xref><offsets xml_i="19790" xml_f="19815" txt_i="13287" txt_f="13312">] However, Utarwuthipong </offsets><italic><offsets xml_i="19823" xml_f="19828" txt_i="13312" txt_f="13317">et al</offsets></italic><offsets xml_i="19837" xml_f="20063" txt_i="13317" txt_f="13543">. reported that consumption of the rice bran oil / palm oil (3 : 1) mixture of oils rich in oleic acid and equivalent in amounts of linoleic acid and palmitic acid could reduce levels of total cholesterol and LDL-cholesterol,[</offsets><xref ref-type="bibr" rid="ref12"><offsets xml_i="20097" xml_f="20099" txt_i="13543" txt_f="13545">12</offsets></xref><offsets xml_i="20106" xml_f="20237" txt_i="13545" txt_f="13676">] as in our previous intervention study with olive oil (known for its high levels of MUFA), where LDL was significantly decreased.[</offsets><xref ref-type="bibr" rid="ref29"><offsets xml_i="20271" xml_f="20273" txt_i="13676" txt_f="13678">29</offsets></xref><offsets xml_i="20280" xml_f="20381" txt_i="13678" txt_f="13779">] Also, in an intervention study with almonds (rich in MUFA) significant serum LDL and TC were seen.[</offsets><xref ref-type="bibr" rid="ref30"><offsets xml_i="20415" xml_f="20417" txt_i="13779" txt_f="13781">30</offsets></xref><offsets xml_i="20424" xml_f="20425" txt_i="13781" txt_f="13782">]</offsets></p><p><offsets xml_i="20432" xml_f="20589" txt_i="13783" txt_f="13940">Consumption of RBO, which is rich in oleic acid has been shown to increase hepatic LDL and CYP7AL (cholesterol 7 a-hydroxylase) expression to a great level.[</offsets><xref ref-type="bibr" rid="ref31"><offsets xml_i="20623" xml_f="20625" txt_i="13940" txt_f="13942">31</offsets></xref><offsets xml_i="20632" xml_f="20639" txt_i="13942" txt_f="13949">] Chen </offsets><italic><offsets xml_i="20647" xml_f="20652" txt_i="13949" txt_f="13954">et al</offsets></italic><offsets xml_i="20661" xml_f="20932" txt_i="13954" txt_f="14225">. speculated that the high MUFA content and unsaponifiable components in RBO may have a synergistic hypercholesterolemic effect. Of the RBO components, phytosterol including gamma oryzanol are thought to be responsible for changes in the blood cholesterol concentration.[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="20965" xml_f="20966" txt_i="14225" txt_f="14226">9</offsets></xref><offsets xml_i="20973" xml_f="21143" txt_i="14226" txt_f="14396">] The increased fecal neutral sterols and bile acids due to RBO-diet consumption can be explained in part by the reduction in cholesterol reabsorption in the intestines.[</offsets><xref ref-type="bibr" rid="ref31"><offsets xml_i="21177" xml_f="21179" txt_i="14396" txt_f="14398">31</offsets></xref><offsets xml_i="21186" xml_f="21575" txt_i="14398" txt_f="14787">] The mechanism of inhibiting cholesterol absorption by phytosterol, whose chemical structure is very similar to that of cholesterol, interferes with the cholesterol movement into micelles and reduces cholesterol absorption in the intestines. In addition, phytosterols are able to increase the excretion of bile acids, which results in the lowering of plasma and liver cholesterol levels.[</offsets><xref ref-type="bibr" rid="ref32"><offsets xml_i="21609" xml_f="21611" txt_i="14787" txt_f="14789">32</offsets></xref><offsets xml_i="21618" xml_f="21619" txt_i="14789" txt_f="14790">]</offsets></p><p><offsets xml_i="21626" xml_f="21705" txt_i="14791" txt_f="14870">In the present study, the RBO used contained 2400 ppm oryzanol. Chen and Cheng[</offsets><xref ref-type="bibr" rid="ref31"><offsets xml_i="21739" xml_f="21741" txt_i="14870" txt_f="14872">31</offsets></xref><offsets xml_i="21748" xml_f="22294" txt_i="14872" txt_f="15418">] reported that oryzanol affected biliary secretion and fecal excretion of cholesterol and bile acids. It significantly increased the fecal excretion of bile acids and neutral sterols. They speculated that the observed hypolipidemic effect of the RBO diet may have been due to increased hepatic LDL-receptor expression, which facilitated the lowering of LDL and increased CYP7A1 expression, which facilitated cholesterol catabolism, and then the upregulation of HMG-CoA reductase expression, to synthesize cholesterol for cholesterol homeostasis </offsets><italic><offsets xml_i="22302" xml_f="22309" txt_i="15418" txt_f="15425">in vivo</offsets></italic><offsets xml_i="22318" xml_f="22320" txt_i="15425" txt_f="15427">.[</offsets><xref ref-type="bibr" rid="ref31"><offsets xml_i="22354" xml_f="22356" txt_i="15427" txt_f="15429">31</offsets></xref><offsets xml_i="22363" xml_f="22481" txt_i="15429" txt_f="15547">] Oxidative damage is a major contributor to the development of cardiovascular pathologies, such as, atherosclerosis.[</offsets><xref ref-type="bibr" rid="ref33"><offsets xml_i="22515" xml_f="22517" txt_i="15547" txt_f="15549">33</offsets></xref><offsets xml_i="22524" xml_f="22689" txt_i="15549" txt_f="15714">] The current recommendations for the prevention of atherosclerosis aim at improving the quality of the diet, by increasing dietary antioxidants, such as vitamin E.[</offsets><xref ref-type="bibr" rid="ref34"><offsets xml_i="22723" xml_f="22725" txt_i="15714" txt_f="15716">34</offsets></xref><offsets xml_i="22732" xml_f="22932" txt_i="15716" txt_f="15916">] The vitamin E isomers (tocopherol and tocotrienols) that are also present in RBO, may confer additional health benefits, particularly antioxidant activity, which has been credited to this compound.[</offsets><xref ref-type="bibr" rid="ref35"><offsets xml_i="22966" xml_f="22968" txt_i="15916" txt_f="15918">35</offsets></xref><xref ref-type="bibr" rid="ref36"><offsets xml_i="23009" xml_f="23011" txt_i="15918" txt_f="15920">36</offsets></xref><offsets xml_i="23018" xml_f="23271" txt_i="15920" txt_f="16173">] Tocotrienols have been suggested to lower TC concentrations in the blood, possibly because of the inhibition of the activity of 3-hydroxy-3 methyl-glutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme, in endogenous cholesterol synthesis.[</offsets><xref ref-type="bibr" rid="ref37"><offsets xml_i="23305" xml_f="23307" txt_i="16173" txt_f="16175">37</offsets></xref><offsets xml_i="23314" xml_f="23322" txt_i="16175" txt_f="16183">] Arora </offsets><italic><offsets xml_i="23330" xml_f="23335" txt_i="16183" txt_f="16188">et al</offsets></italic><offsets xml_i="23344" xml_f="23474" txt_i="16188" txt_f="16318">. reported that after consumption of RBO for three months in hyperlipidemic subjects, a lower incidence of elevated TAG was seen.[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="23508" xml_f="23510" txt_i="16318" txt_f="16320">11</offsets></xref><offsets xml_i="23517" xml_f="23697" txt_i="16320" txt_f="16500">] In another study, 75 ml of RBO, thrice daily as the cooking medium with breakfast, lunch, and dinner, for a period of 50 days was used and significant reduction in TAG was seen.[</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="23731" xml_f="23733" txt_i="16500" txt_f="16502">10</offsets></xref><offsets xml_i="23740" xml_f="23805" txt_i="16502" txt_f="16567">] Our results were not consistent with the observations of Arora </offsets><italic><offsets xml_i="23813" xml_f="23818" txt_i="16567" txt_f="16572">et al</offsets></italic><offsets xml_i="23827" xml_f="23845" txt_i="16572" txt_f="16590">. and Rajnarayana </offsets><italic><offsets xml_i="23853" xml_f="23858" txt_i="16590" txt_f="16595">et al</offsets></italic><offsets xml_i="23867" xml_f="23960" txt_i="16595" txt_f="16688">., which at a higher amount of RBO and longer study period resulted in the reduction of TAG.[</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="23994" xml_f="23996" txt_i="16688" txt_f="16690">10</offsets></xref><xref ref-type="bibr" rid="ref11"><offsets xml_i="24037" xml_f="24039" txt_i="16690" txt_f="16692">11</offsets></xref><offsets xml_i="24046" xml_f="24164" txt_i="16692" txt_f="16810">] In the present study, no significant change occurred in HDL. This finding is in agreement with the earlier reports.[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="24197" xml_f="24198" txt_i="16810" txt_f="16811">9</offsets></xref><xref ref-type="bibr" rid="ref11"><offsets xml_i="24239" xml_f="24241" txt_i="16811" txt_f="16813">11</offsets></xref><xref ref-type="bibr" rid="ref15"><offsets xml_i="24282" xml_f="24284" txt_i="16813" txt_f="16815">15</offsets></xref><xref ref-type="bibr" rid="ref16"><offsets xml_i="24325" xml_f="24327" txt_i="16815" txt_f="16817">16</offsets></xref><xref ref-type="bibr" rid="ref25"><offsets xml_i="24368" xml_f="24370" txt_i="16817" txt_f="16819">25</offsets></xref><offsets xml_i="24377" xml_f="24455" txt_i="16819" txt_f="16897">] Furthermore, in our study that was similar to the result of a recent study,[</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="24489" xml_f="24491" txt_i="16897" txt_f="16899">16</offsets></xref><offsets xml_i="24498" xml_f="24751" txt_i="16899" txt_f="17152">] the ability of RBO to reduce the atherogenic ratio of TC / HDL concentration to a great level (7.3%), may be indicative of further health benefits that can be attributed to this product. In some intervention studies, a three-day food record was used,[</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="24785" xml_f="24787" txt_i="17152" txt_f="17154">16</offsets></xref><xref ref-type="bibr" rid="ref38"><offsets xml_i="24828" xml_f="24830" txt_i="17154" txt_f="17156">38</offsets></xref><offsets xml_i="24837" xml_f="25570" txt_i="17156" txt_f="17889">] to reach a more accurate estimation of energy and macronutrient intake. The patients of this study were asked to record their food intake for one week. Our study had some limitations, such as, the small number of participants and hyperlipidemic patients, who did not receive lipid-lowering drugs. The strengths of the study were that it reproduced real-life conditions with home prepared foods for diet, and use of supplemental foods that were commonly available and consumed by the public. RBO, which contained these compounds, could become an important functional food, with cardiovascular health benefits. The use of RBO, together with dietary modification, may have implications for reducing the risk of cardiovascular disease.</offsets></p><p><offsets xml_i="25577" xml_f="25817" txt_i="17890" txt_f="18130">In conclusion, the result of the present study showed that short-term consumption of RBO with a low-calorie diet, as a part of healthy diet, improved the atherogenic lipid profiles and cardiovascular risk factors in hyperlipidemic patients.</offsets></p></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p>This study was supported by grant No. 28.20.2225 from the Deputy of Research, Qazvin University of Medical Sciences, Qazvin, Iran. This clinical trial is registered in the ClinicalTrail.gov by number: Thanks are due to Mr. M. Satvat, Director Manager of Arian Top Noosh Company, Tehran, Iran, for the dedication of rice bran oil (King rice bran oil, Bangkok, Thailand). We would also like to thank Dr. Saeed Assefzadeh, Deputy of Research, Qazvin University of Medical Sciences, for consultation, and Mrs. Mohtaram Adineh, Laboratory of Human Nutrition, Qazvin University of Medical Sciences, for analyzing the data on the diet composition.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durrington</surname><given-names>PN</given-names></name><name><surname>Prais</surname><given-names>H</given-names></name><name><surname>Bhatnagar</surname><given-names>D</given-names></name><name><surname>France</surname><given-names>M</given-names></name><name><surname>Crowley</surname><given-names>V</given-names></name><name><surname>Khan</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Indications for cholesterolw-lowering medication: Comparison of risk-assessment methods</article-title><source>Lancet</source><year>1999</year><volume>23</volume><issue>353</issue><fpage>278</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">9929020</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azadbakht</surname><given-names>L</given-names></name><name><surname>Haghighatdoost</surname><given-names>F</given-names></name><name><surname>Esmaillzadeh</surname><given-names>A</given-names></name></person-group><article-title>Legumes: A component of a healthy diet</article-title><source>J Res Med Sci</source><year>2011</year><volume>16</volume><fpage>121</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">22091219</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Abumweis</surname><given-names>SS</given-names></name><name><surname>Barake</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>PJ</given-names></name></person-group><article-title>Plant sterols / stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trials</article-title><source>Food Nutr Res</source><year>2008</year><date-in-citation>Last cited in 2008</date-in-citation><fpage>52</fpage><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.foodandnutritionresearch.net">http://www.foodandnutritionresearch.net</uri></comment></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>AA</given-names></name><name><surname>Sami</surname><given-names>SA</given-names></name><name><surname>Khan</surname><given-names>FA</given-names></name></person-group><article-title>Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus types I and II</article-title><source>J Nutr Biochem</source><year>2002</year><volume>13</volume><fpage>175</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">11893482</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>TA</given-names></name><name><surname>Nicolosi</surname><given-names>RJ</given-names></name><name><surname>Woolfrey</surname><given-names>B</given-names></name><name><surname>Kritchevsky</surname><given-names>D</given-names></name></person-group><article-title>Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters</article-title><source>J Nutr Biochem</source><year>2007</year><volume>18</volume><fpage>105</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16713234</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>MK</given-names></name><name><surname>Rhee</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>IH</given-names></name><name><surname>Lee</surname><given-names>KW</given-names></name></person-group><article-title>Beneficial effect of the unsaponifiable matter from rice bran oil on oxidative stress <italic>in vitro</italic> compared with ά-tocopherol</article-title><source>J Sci Food Agric</source><year>2005</year><volume>85</volume><fpage>493</fpage><lpage>8</lpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicero</surname><given-names>AF</given-names></name><name><surname>Gaddi</surname><given-names>A</given-names></name></person-group><article-title>Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions</article-title><source>Phytother Res</source><year>2001</year><volume>5</volume><fpage>277</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">11406848</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>PR</given-names></name><name><surname>Chingmin</surname><given-names>E</given-names></name></person-group><article-title>Various high monounsaturated edible oils might effect plasma lipids differently in man</article-title><source>Nutr Res</source><year>1995</year><volume>15</volume><fpage>615</fpage><lpage>21</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>MN</given-names></name><name><surname>Zock</surname><given-names>PL</given-names></name><name><surname>Meijer</surname><given-names>GW</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name></person-group><article-title>Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans</article-title><source>Am J Clin Nutr</source><year>2000</year><volume>72</volume><fpage>1510</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11101479</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajnarayana</surname><given-names>K</given-names></name><name><surname>Prabhakar</surname><given-names>MC</given-names></name><name><surname>Krishna</surname><given-names>DR</given-names></name></person-group><article-title>Influence of rice bran oil on serum lipid peroxides and lipids in human subjects</article-title><source>Indian J Physiol Pharmacol</source><year>2001</year><volume>45</volume><fpage>442</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11883150</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Goel</surname><given-names>SK</given-names></name><name><surname>Singh</surname><given-names>US</given-names></name></person-group><article-title>Use of rice bran oil in patients with hyperlipidaemia</article-title><source>Natl Med J India</source><year>2005</year><volume>18</volume><fpage>292</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16483027</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utarwuthipong</surname><given-names>T</given-names></name><name><surname>Komindr</surname><given-names>S</given-names></name><name><surname>Pakpeankitvatana</surname><given-names>V</given-names></name><name><surname>Songchitsomboon</surname><given-names>S</given-names></name><name><surname>Thongmuang</surname><given-names>N</given-names></name></person-group><article-title>Small dense low-density lipoprotein concentration and oxidative susceptibility changes after consumption of soybean oil, rice bran oil, palm oil and mixed rice bran / palm oil in hypercholesterolaemic women</article-title><source>J Int Med Res</source><year>2009</year><volume>37</volume><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">19215678</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabassum</surname><given-names>S</given-names></name><name><surname>Aggarwal</surname><given-names>S</given-names></name><name><surname>Ali</surname><given-names>SM</given-names></name><name><surname>Beg</surname><given-names>ZH</given-names></name><name><surname>Khan</surname><given-names>AS</given-names></name><name><surname>Afzal</surname><given-names>K</given-names></name></person-group><article-title>Effect of rice bran oil on the lipid profile of steroid responsive nephritic syndrome</article-title><source>Indian J Nephrol</source><year>2005</year><volume>15</volume><fpage>10</fpage><lpage>3</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ausman</surname><given-names>LM</given-names></name><name><surname>Rong</surname><given-names>N</given-names></name><name><surname>Nicolosi</surname><given-names>RJ</given-names></name></person-group><article-title>Hypocholesterolemic effect of physically refined rice bran oil: Studies of cholesterol metabolism and early atherosclerosis in hypercholesterolemic hamsters</article-title><source>J Nutr Biochem</source><year>2005</year><volume>16</volume><fpage>521</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16115540</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuriyan</surname><given-names>R</given-names></name><name><surname>Gopinath</surname><given-names>N</given-names></name><name><surname>Vaz</surname><given-names>M</given-names></name><name><surname>Kurpad</surname><given-names>AV</given-names></name></person-group><article-title>Use of rice bran oil in patients with hyperlipidaemia</article-title><source>Natl Med J India</source><year>2005</year><volume>18</volume><fpage>292</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16483027</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eady</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>A</given-names></name><name><surname>Willis</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>R</given-names></name><name><surname>Frampton</surname><given-names>C</given-names></name></person-group><article-title>Consumption of a plant sterol-based spread derived from rice bran oil is effective at reducing plasma lipid levels in mildly hypercholesterolaemic individuals</article-title><source>Br J Nutr</source><year>2011</year><volume>15</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">21320365</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Ausman</surname><given-names>LM</given-names></name><name><surname>Carrasco</surname><given-names>W</given-names></name><name><surname>Gualtieri</surname><given-names>LJ</given-names></name><name><surname>Jenner</surname><given-names>JL</given-names></name><name><surname>Ordovas</surname><given-names>JM</given-names></name><etal></etal></person-group><article-title>Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1994</year><volume>14</volume><fpage>549</fpage><lpage>56</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noroozi</surname><given-names>M</given-names></name><name><surname>Zavoshy</surname><given-names>R</given-names></name><name><surname>Jahanihashemi</surname><given-names>H</given-names></name><name><surname>Asefzadeh</surname><given-names>S</given-names></name></person-group><article-title>The effect of soy protein with low calorie diet on blood lipids in hyperlipidemic type 2 diabetic patients</article-title><source>J Food Lipids</source><year>2008</year><volume>15</volume><fpage>398</fpage><lpage>406</lpage></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noroozi</surname><given-names>M</given-names></name><name><surname>Zavoshy</surname><given-names>R</given-names></name><name><surname>Jahanihashemi</surname><given-names>H</given-names></name></person-group><article-title>The effect of low calorie diet with soy protein on cardiovascular risk factors in hyperlipidemic patients</article-title><source>Pak J Biol Sci</source><year>2011</year><volume>14</volume><fpage>282</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21870630</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noroozi</surname><given-names>M</given-names></name><name><surname>Zavoshy</surname><given-names>R</given-names></name><name><surname>Jahanihashemi</surname><given-names>H</given-names></name></person-group><article-title>The effect of low calorie diet with canola oil on blood lipids in hyperlipidemic patients</article-title><source>J Food Nutr Res</source><year>2009</year><volume>48</volume><fpage>178</fpage><lpage>82</lpage></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>M</given-names></name><name><surname>Scholnick</surname><given-names>HR</given-names></name><name><surname>Morfin</surname><given-names>R</given-names></name></person-group><article-title>Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions</article-title><source>J Lipid Res</source><year>1970</year><volume>11</volume><fpage>583</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">4100998</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahraki</surname><given-names>T</given-names></name><name><surname>Shahraki</surname><given-names>M</given-names></name><name><surname>Roudbari</surname><given-names>M</given-names></name><name><surname>Gargari</surname><given-names>BP</given-names></name></person-group><article-title>Determination of the leading central obesity index among cardiovascular risk factors in Iranian women</article-title><source>Food Nutr Bull</source><year>2008</year><volume>29</volume><fpage>43</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18510204</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzawa</surname><given-names>CW</given-names></name><name><surname>Adair</surname><given-names>LS</given-names></name><name><surname>Avila</surname><given-names>JL</given-names></name><name><surname>Cadungog</surname><given-names>JH</given-names></name><name><surname>Le</surname><given-names>NA</given-names></name></person-group><article-title>Atherogenic lipid profiles in Filipino adolescents with low body mass index and low dietary fat intake</article-title><source>Am J Hum Biol</source><year>2003</year><volume>15</volume><fpage>688</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">12953181</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azadbakht</surname><given-names>L</given-names></name><name><surname>Surkan</surname><given-names>PJ</given-names></name><name><surname>Esmaillzadeh</surname><given-names>A</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients</article-title><source>J Nutr</source><year>2011</year><volume>141</volume><fpage>1083</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21525259</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Most</surname><given-names>M</given-names></name><name><surname>Tulley</surname><given-names>RM</given-names></name><name><surname>Morales</surname><given-names>S</given-names></name><name><surname>Lefevre</surname><given-names>M</given-names></name></person-group><article-title>Rice bran oil, not fiber, lowers cholesterol in humans</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>81</volume><fpage>64</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15640461</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>A</given-names></name><name><surname>Rein</surname><given-names>D</given-names></name><name><surname>Schäfer</surname><given-names>A</given-names></name><name><surname>Monnard</surname><given-names>I</given-names></name><name><surname>Gremaud</surname><given-names>G</given-names></name><name><surname>Lambelet</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol, in mildly hypercholesterolemic men</article-title><source>Eur J Nutr</source><year>2005</year><volume>44</volume><fpage>163</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">15309429</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Brands</surname><given-names>M</given-names></name><name><surname>Carnethon</surname><given-names>M</given-names></name><name><surname>Daniels</surname><given-names>S</given-names></name><name><surname>Franch</surname><given-names>HA</given-names></name><etal></etal></person-group><article-title>Diet and lifestyle recommendations revision. A scientific statement from the American Heart Association Nutrition Committee</article-title><source>Circulation</source><year>2006</year><volume>114</volume><fpage>82</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">16785338</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><article-title>National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>3143</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">12485966</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noroozi</surname><given-names>M</given-names></name><name><surname>Zavoshy</surname><given-names>R</given-names></name><name><surname>Jahanihashemi</surname><given-names>H</given-names></name></person-group><article-title>Effect of olive oil with low calorie diet on blood lipids in hyperlipidemic patients</article-title><source>Pol J Food Nutr Sci</source><year>2012</year><volume>62</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalali-Khanabadi</surname><given-names>BA</given-names></name><name><surname>Mozaffari-Khosravi</surname><given-names>H</given-names></name><name><surname>Parsaeyan</surname><given-names>N</given-names></name></person-group><article-title>Effects of almond dietary supplementation on coronary heart disease lipid risk factors and serum lipid oxidation parameters in men with mild hyperlipidemia</article-title><source>J Altern Complement Med</source><year>2010</year><volume>16</volume><fpage>1279</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">21114415</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CW</given-names></name><name><surname>Cheng</surname><given-names>HH</given-names></name></person-group><article-title>A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin / nicotinamide-induced type 2 diabetes</article-title><source>J Nutr</source><year>2006</year><volume>136</volume><fpage>1472</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16702306</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Bradwin</surname><given-names>G</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name></person-group><article-title>Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women</article-title><source>JAMA</source><year>2005</year><volume>294</volume><fpage>326</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">16030277</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chisolm</surname><given-names>GM</given-names></name><name><surname>Steinberg</surname><given-names>D</given-names></name></person-group><article-title>The oxidative modification hypothesis of atherogenesis: An overview</article-title><source>Free Radic Biol Med</source><year>2000</year><volume>28</volume><fpage>1815</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">10946223</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Keefe</surname><given-names>JR</given-names></name><name><surname>Lavie</surname><given-names>JR</given-names></name><name><surname>McCallister</surname><given-names>BD</given-names></name></person-group><article-title>Insights into the pathogenesis and prevention of coronary artery disease</article-title><source>Mayo Clin Proc</source><year>1995</year><volume>70</volume><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">7808056</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostlund</surname><given-names>RE</given-names></name></person-group><article-title>Phytosterols, cholesterol absorption and healthy diets</article-title><source>Lipids</source><year>2007</year><volume>42</volume><fpage>41</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17393209</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minhajuddin</surname><given-names>M</given-names></name><name><surname>Beg</surname><given-names>ZH</given-names></name><name><surname>Iqbal</surname><given-names>J</given-names></name></person-group><article-title>Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats</article-title><source>Food Chem Toxicol</source><year>2005</year><volume>43</volume><fpage>747</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15778015</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>N</given-names></name><name><surname>Qureshi</surname><given-names>AA</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Packer</surname><given-names>L</given-names></name><name><surname>Fuchs</surname><given-names>J</given-names></name></person-group><article-title>Novel hypocholesterolemic agents with antioxidant properties</article-title><source>Vitamin E in health and disease</source><year>1993</year><publisher-loc>New York</publisher-loc><publisher-name>Marcel Decker</publisher-name><fpage>247</fpage><lpage>67</lpage></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sodergren</surname><given-names>E</given-names></name><name><surname>Gustafsson</surname><given-names>IB</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Nourooz-Zadeh</surname><given-names>J</given-names></name><name><surname>Nälsén</surname><given-names>C</given-names></name><name><surname>Turpeinen</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>A diet containing rapeseed oil-based fats does not increase lipid peroxidation in humans when compared to a diet rich in saturated fatty acids</article-title><source>Eur J Clin Nutr</source><year>2001</year><volume>55</volume><fpage>922</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11641740</pub-id></element-citation></ref></ref-list></back></article>